We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

94 hedge funds and large institutions have $126M invested in Alaunos Therapeutics in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 32 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more call options, than puts

Call options by funds: $3.2M | Put options by funds: $2.44M

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

2% more funds holding

Funds holding: 92 → 94 (+2)

31% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 32

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

38% less capital invested

Capital invested by funds: $204M → $126M (-$77.5M)

Holders
94
Holders Change
+2
Holders Change %
+2.17%
% of All Funds
2.73%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
14
Increased
22
Reduced
32
Closed
11
Calls
$3.2M
Puts
$2.44M
Net Calls
+$754K
Net Calls Change
-$410K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$862K
2
Goldman Sachs
Goldman Sachs
New York
+$323K
3
Nomura Holdings
Nomura Holdings
Japan
+$308K
4
Morgan Stanley
Morgan Stanley
New York
+$271K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$248K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.11M
2
BGA
Belmont Global Advisors
Texas
-$2.61M
3
State Street
State Street
Massachusetts
-$1.63M
4
Group One Trading
Group One Trading
Illinois
-$588K
5
Barclays
Barclays
United Kingdom
-$540K
Name Holding Trade Value Shares
Change 		Change in
Stake
SGAM
26
Smith Group Asset Management
Texas
$625K -$2.89K -6 -0.4%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$394K +$2.89K +6 +0.6%
Nomura Holdings
28
Nomura Holdings
Japan
$394K +$308K +639 +181%
Barclays
29
Barclays
United Kingdom
$366K -$540K -1,121 -48%
AQR Capital Management
30
AQR Capital Management
Connecticut
$335K +$6.75K +14 +2%
Goldman Sachs
31
Goldman Sachs
New York
$322K +$323K +669 +461%
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$307K +$28.9K +60 +8%
ARTA
33
A.R.T. Advisors
New York
$306K +$11.1K +23 +3%
TA
34
Teachers Advisors
New York
$304K – – –
Deutsche Bank
35
Deutsche Bank
Germany
$272K -$38.6K -80 -10%
SWA
36
SFMG Wealth Advisors
Texas
$264K – – –
AllianceBernstein
37
AllianceBernstein
Tennessee
$256K – – –
Swiss National Bank
38
Swiss National Bank
Switzerland
$252K – – –
Citadel Advisors
39
Citadel Advisors
Florida
$242K +$96.9K +201 +49%
PPA
40
Parametric Portfolio Associates
Washington
$219K -$13K -27 -5%
AIG
41
American International Group
New York
$193K – – –
CS
42
Credit Suisse
Switzerland
$191K -$50.6K -105 -18%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$171K – – –
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$167K +$64.6K +134 +47%
NFA
45
Nationwide Fund Advisors
Ohio
$165K -$3.86K -8 -2%
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$159K – – –
American Century Companies
47
American Century Companies
Missouri
$150K +$183K +379 New
BA
48
BlackRock Advisors
Delaware
$144K -$2.89K -6 -2%
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$144K – – –
VOYA Investment Management
50
VOYA Investment Management
Georgia
$134K – – –
1
2
3 4 5

TCRT Hedge Fund Activity: Q3 2014 in Review

94 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q3 2014, worth a combined $126M — down 38% from $204M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TCRT positions and 11 closed out — a net gain of 3 holders — while 22 added to existing stakes and 32 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $862K. The largest seller was Fidelity Investments, cutting an estimated $4.11M.

  • 94 institutional investors held Alaunos Therapeutics (TCRT) as of Q3 2014, up from 92 in Q2 2014.
  • Funds reported $126M of Alaunos Therapeutics stock for Q3 2014, down 38% quarter-over-quarter.
  • 14 funds opened new Alaunos Therapeutics positions in Q3 2014 and 11 closed out, a net change of +3 holders.
  • The largest Alaunos Therapeutics buyer in Q3 2014 was Renaissance Technologies, an estimated $862K added.
  • The largest Alaunos Therapeutics seller in Q3 2014 was Fidelity Investments, an estimated $4.11M sold.

Based on aggregated 13F filings for Q3 2014.